Screening of 185DelAG, 1014DelGT and 3889DelAG BRCA1 mutations in breast cancer patients from north-east india

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 11, 2012, Pages 5871-5874

  Hansa, Jagadish ^a   Kannan, Ravi ^b   Ghosh, Sankar Kumar ^a  

^a ASSAM UNIVERSITY   (India)

^b Cachar Cancer Hospital and Research Centre   (India)

Author keywords

BRCA1; Breast cancer cases; Mutations; North East India

Indexed keywords

EID: 84874104566     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.11.5871     Document Type: Article

References (30)

1. Agarwal G, Ramakant P (2008). Breast cancer care in India: The current scenario and the challenges for the future. Breast Cancer, 3, 21-7.
2. Bar-Sade RB, Kruglikova A, Modan B, et al (1998). The 185DelAG BRCA1 mutation originated before the dispersion of Jews in the diaspora and is not limited to Ashkenazim. Human Molecular Genetics, 7, 801-5.
3. Brozek I, Cybulska C, Ratajska M, et al (2011). Prevalence of the most frequent BRCA1 mutations in polish population. J Appl Genetics, 52, 325-30.
4. Claus E, Risch N, Thompson WD (1994). Autosomal dominant inheritance of early onset breast cancer. Cancer, 73, 643-51.
5. Datta K, Biswas J (2009). Influence of dietary habits, physical activity and affluence factors on breast cancer in East India - A case-control Study. Asian Pac J Cancer Prev, 10, 219-22.
6. Farooq A, Naveed AK, Azeem Z, Ahmad T (2011). Breast and ovarian cancer risk due to prevalence of BRCA1 and BRCA2 variants in Pakistani population: A Pakistani database report. J Oncol, 2011, 1-8.
7. Ford D, Easton DF, Stratton M, et al (1998). Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet, 62, 676-89.
8. Ghosh SK, Choudhury B, Hansa J, et al (2011). HPV testing for suspected cervical cancer patients from Southern Assam by fast-PCR. Asian Pac J Cancer Prev, 12, 749-51.
9. Greenberg RA (2008). Recognition of DNA double strand breaks by the BRCA1 tumor suppressor network. Chromosoma, 117, 305-17.
10. Hall JM, Lee MK, Newman B, et al (1990). Linkage of earlyonset familial breast cancer to chromosome17q21. Sci, 250, 1684-9
11. Hedau S, Jain N, Syed A, Husain, Das BC (2004). Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India. Breast Cancer Res and Treatment, 88, 177-86. http://research.nhgri.nih.gov/bic/: Breast Cancer information core (NHGRI)
12. Kumar BV, Lakhotia S, Ankathil R, et al (2002). Germline BRCA1 mutation analysis in Indian Breast/Ovarian cancer families. Cancer Biol Ther, 1, 18-21.
13. Lakhotia, Somasundaram (2010). Conformation Sensitive Gel Electrophoresis for detecting BRCA1 mutations. Methods in Molecular Biol, 223, 403-14.
14. Liang SX, Pearl M, Liang S, et al (2011). Personal history of breast cancer as a significant risk factor for endometrial serous carcinoma in women aged 55 years old or younger. Int J Cancer, 128, 763-70.
15. Liede A, Malik IA, Aziz Z, et al (2009). Contribution of BRCA1 and BRCA2 Mutations to Breast and Ovarian Cancer in Pakistan. Am J Hum Genet, 71, 595-606.
16. Mangtani P, Maringe C, Rachet B, Coleman MP, Silva IDS (2010). Cancer mortality in ethnic South Asian migrants in England and Wales (1993-2003): patterns in the overall population and in first and subsequent generations. Br J Cancer, 102, 1438-43.
17. Mathew A, Pandey M, Rajan B (2004). Do younger woman with non-metastatic and non-inflammatory breast carcinoma have poor prognosis? World J Surg Oncol, 2, 2.
18. Metcalfe K, Lubinski J, Lynch HT, et al (2010). Family history of cancer and cancer risks in women with BRCA1 or BRCA2 mutations. JNCI, 102, 1874-78.
19. Miki Y, Swensen J, Shattuck-Eidens D, et al (1994). A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science, 266, 66-71.
20. Narod SA (2011). Screening of women at high risk for breast cancer. Prev Med, 52, 127-30.
21. Roy R, Chun J, Powell SN (2012). BRCA1 &BRCA2: different roles in a common pathway of genome protection. Nature Reviews Cancer, 12, 68-78.
22. Sandhu DS, Sandhu S, Karwasra RK, Marwah S (2010). Profile of breast cancer patients at a tertiary care hospital in North India. Indian J Cancer, 17, 16-22.
23. Saxena S, Kaushal M, Sharma J, Zomawia E Kapur S (2010). Genomic alteraions in breast cancer patients from Northeast India using 10K SNP arrays. Genome Biol, 11, 34.
24. Saxena S, Chakraborty A, Kaushal M, et al (2006). Contribution of germline BRCA1 and BRCA2 sequence alterations to breast cancer in Northern India. BMC Med Genet, 7, 75.
25. Saxena S, Rekhi B, Bansal A, et al (2005). Clinico-morphological patterns of breast cancer including family history in a New Delhi hospital, India-A cross-sectional study.World J Surg Oncol, 3, 1-8.
26. Thirthagiri E, Lee SY, Kang P, et al (2008). Evaluation of BRCA1 and BRCA2 mutations and risk-prediction models in a typical Asian country (Malaysia) with a relatively low incidence of breast cancer. Breast Cancer Res, 10, R59.
27. Valarmathi MT, Sawhney M, Suryanarayana SV, et al (2004). Novel germline mutations in the BRCA1 and BRCA2 genes in Indian breast and breast-ovarian cancer families. Hum Mutat, 23, 205.
28. Wong NS, Anderson BO, Khoo KS, et al (2009). Management of HER2-positive breast cancer in Asia: consensus statement from Asian Oncology Summit 2009. Lancet Oncol, 10, 1077-85.
29. Wooster R, Weber BL (2010). Breast and ovarian cancer. N Engl J Med 2003, 348, 2339-47.
30. Zhang H, Somasundaram K, Peng Y (????). BRCA1 physically associates with p53 and stimulates its transcriptional activity. Oncogene, 16, 1713-1721.